Nueterra Capital’s team includes 6 investment professionals, and 2 admin related team members. The average tenure for the Firm’s senior team is 21 years.
Sign-up to view Nueterra Capital’s full profile and discover more small growth capital firm investors just like it.
11350 Tomahawk Creek Parkway, Suite 200,
Leawood,
Kansas
66211
United States
(913) 387-0515
www.nueterra.com
info@nuehealth.com
| Name | Title | Phone | Office | |
|---|---|---|---|---|
 |
CEO | Leawood | ||
|
As Nueterra Capital CEO, Jeremy oversees all firm-wide operations, provides leadership, and is responsible for setting the strategic direction of the company. Jeremy joined Nueterra Capital in 2001 as one of the company’s first investment executives, focused on investments in the healthcare provider sector. Prior to that, he was CEO of Astoria Healthcare Properties, which focuses on real estate investments and development. Jeremy currently serves on the Investment Committee for Fund I, Fund II, Fund III, and Fund IV, and serves on the board for NueHealth, Axiom, Casetabs, Triggr Health, and HealthJoy. Since 2011, Jeremy has served as Chairman of the Board for Astoria Healthcare Properties. He received a B.S. degree in Business Administration from the University of Kansas. |
||||
| Function: Investment | ||||
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
